These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27719781)

  • 1. A Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms of Menopause.
    Fantasia HC
    Nurs Womens Health; 2016; 20(5):511-518. PubMed ID: 27719781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
    Alexander IM; Moore A
    J Am Acad Nurse Pract; 2007 Mar; 19(3):152-63. PubMed ID: 17341283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.
    Umland EM
    J Manag Care Pharm; 2008 Apr; 14(3 Suppl):14-9. PubMed ID: 18439062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy for the management of menopause symptoms.
    Collins Fantasia H; Sutherland MA
    J Obstet Gynecol Neonatal Nurs; 2014; 43(2):226-35; quiz E18-9. PubMed ID: 24502325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and nonhormonal treatment of vasomotor symptoms.
    Krause MS; Nakajima ST
    Obstet Gynecol Clin North Am; 2015 Mar; 42(1):163-79. PubMed ID: 25681847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing risks and benefits of nonhormonal treatments for vasomotor symptoms in perimenopausal and postmenopausal women.
    Thacker HL
    J Womens Health (Larchmt); 2011 Jul; 20(7):1007-16. PubMed ID: 21675874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Nonhormonal Treatment for Vasomotor Symptoms of Menopause.
    Javernick JA
    Nurs Womens Health; 2024 Feb; 28(1):80-84. PubMed ID: 38161058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical appraisal of paroxetine for the treatment of vasomotor symptoms.
    Carroll DG; Lisenby KM; Carter TL
    Int J Womens Health; 2015; 7():615-24. PubMed ID: 26124682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society.
    Menopause; 2015 Nov; 22(11):1155-72; quiz 1173-4. PubMed ID: 26382310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Menopausal Symptoms: A Review.
    Crandall CJ; Mehta JM; Manson JE
    JAMA; 2023 Feb; 329(5):405-420. PubMed ID: 36749328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
    Pinkerton JV; Joffe H; Kazempour K; Mekonnen H; Bhaskar S; Lippman J
    Menopause; 2015 Jan; 22(1):50-8. PubMed ID: 25137243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
    Handley AP; Williams M
    J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
    Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
    Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate.
    Carris N; Kutner S; Reilly-Rogers S
    Ann Pharmacother; 2014 Oct; 48(10):1343-9. PubMed ID: 25028744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of paroxetine for the treatment of vasomotor symptoms.
    Slaton RM; Champion MN; Palmore KB
    J Pharm Pract; 2015 Jun; 28(3):266-74. PubMed ID: 25107421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom experience of Filipino American midlife women.
    Berg JA; Taylor DL
    Menopause; 1999; 6(2):105-14. PubMed ID: 10374216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing vasomotor symptoms in women after cancer.
    Pinkerton JV; Santen RJ
    Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.